Sarno S - Search Results

1

How can a traffic light properly work if it is always green? The paradox of CK2 signaling.

Borgo C, D'Amore C, Cesaro L, Sarno S, Pinna LA, Ruzzene M, Salvi M. Borgo C, et al. Among authors: sarno s. Crit Rev Biochem Mol Biol. 2021 Aug;56(4):321-359. doi: 10.1080/10409238.2021.1908951. Epub 2021 Apr 11. Crit Rev Biochem Mol Biol. 2021. PMID: 33843388 Review.

2

Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.

Meggio F, Pagano MA, Moro S, Zagotto G, Ruzzene M, Sarno S, Cozza G, Bain J, Elliott M, Deana AD, Brunati AM, Pinna LA. Meggio F, et al. Among authors: sarno s. Biochemistry. 2004 Oct 12;43(40):12931-6. doi: 10.1021/bi048999g. Biochemistry. 2004. PMID: 15461466 Free article.

3

Protein kinase CK2 as a druggable target.

Sarno S, Pinna LA. Sarno S, et al. Mol Biosyst. 2008 Sep;4(9):889-94. doi: 10.1039/b805534c. Epub 2008 Jun 12. Mol Biosyst. 2008. PMID: 18704226 Review.

4

Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells.

Salvi M, Xu D, Chen Y, Cabrelle A, Sarno S, Pinna LA. Salvi M, et al. Among authors: sarno s. Biochem Biophys Res Commun. 2009 Sep 25;387(3):606-10. doi: 10.1016/j.bbrc.2009.07.067. Epub 2009 Jul 17. Biochem Biophys Res Commun. 2009. PMID: 19616514

5

The p23 co-chaperone protein is a novel substrate of CK2 in Arabidopsis.

Tosoni K, Costa A, Sarno S, D'Alessandro S, Sparla F, Pinna LA, Zottini M, Ruzzene M. Tosoni K, et al. Among authors: sarno s. Mol Cell Biochem. 2011 Oct;356(1-2):245-54. doi: 10.1007/s11010-011-0969-0. Epub 2011 Jul 7. Mol Cell Biochem. 2011. PMID: 21735091

6

Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy - potential clinical relevance.

D'Amore C, Borgo C, Sarno S, Salvi M. D'Amore C, et al. Among authors: sarno s. Cell Oncol (Dordr). 2020 Dec;43(6):1003-1016. doi: 10.1007/s13402-020-00566-w. Epub 2020 Oct 14. Cell Oncol (Dordr). 2020. PMID: 33052585 Free PMC article. Review.

7

Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Borgo C, D'Amore C, Sarno S, Salvi M, Ruzzene M. Borgo C, et al. Among authors: sarno s. Signal Transduct Target Ther. 2021 May 17;6(1):183. doi: 10.1038/s41392-021-00567-7. Signal Transduct Target Ther. 2021. PMID: 33994545 Free PMC article. Review.

8

Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight.

De Moliner E, Moro S, Sarno S, Zagotto G, Zanotti G, Pinna LA, Battistutta R. De Moliner E, et al. Among authors: sarno s. J Biol Chem. 2003 Jan 17;278(3):1831-6. doi: 10.1074/jbc.M209367200. Epub 2002 Nov 4. J Biol Chem. 2003. PMID: 12419810 Free article.

9

Tyrosine phosphorylation of protein kinase CK2 by Src-related tyrosine kinases correlates with increased catalytic activity.

Donella-Deana A, Cesaro L, Sarno S, Ruzzene M, Brunati AM, Marin O, Vilk G, Doherty-Kirby A, Lajoie G, Litchfield DW, Pinna LA. Donella-Deana A, et al. Among authors: sarno s. Biochem J. 2003 Jun 15;372(Pt 3):841-9. doi: 10.1042/BJ20021905. Biochem J. 2003. PMID: 12628006 Free PMC article.

10

Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).

Sarno S, de Moliner E, Ruzzene M, Pagano MA, Battistutta R, Bain J, Fabbro D, Schoepfer J, Elliott M, Furet P, Meggio F, Zanotti G, Pinna LA. Sarno S, et al. Biochem J. 2003 Sep 15;374(Pt 3):639-46. doi: 10.1042/BJ20030674. Biochem J. 2003. PMID: 12816539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page